NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,640,000 | -31.8% | 243,887 | -23.6% | 0.01% | -28.6% |
| Q4 2021 | $25,877,000 | -20.5% | 319,193 | +14.1% | 0.01% | -30.0% |
| Q3 2021 | $32,546,000 | -10.2% | 279,651 | +27.9% | 0.01% | -9.1% |
| Q2 2021 | $36,236,000 | +90.8% | 218,566 | +60.5% | 0.01% | +83.3% |
| Q1 2021 | $18,992,000 | -21.3% | 136,144 | -2.3% | 0.01% | -25.0% |
| Q4 2020 | $24,129,000 | +26.6% | 139,392 | +1.9% | 0.01% | +14.3% |
| Q3 2020 | $19,059,000 | +13.8% | 136,820 | -2.4% | 0.01% | 0.0% |
| Q2 2020 | $16,747,000 | +12.9% | 140,180 | -5.6% | 0.01% | 0.0% |
| Q1 2020 | $14,839,000 | -16.3% | 148,418 | -1.6% | 0.01% | 0.0% |
| Q4 2019 | $17,734,000 | +14.5% | 150,876 | -16.3% | 0.01% | +16.7% |
| Q3 2019 | $15,494,000 | +11.5% | 180,229 | -15.9% | 0.01% | 0.0% |
| Q2 2019 | $13,890,000 | +23.7% | 214,254 | +19.3% | 0.01% | +20.0% |
| Q1 2019 | $11,229,000 | -29.0% | 179,629 | -35.2% | 0.01% | -28.6% |
| Q3 2018 | $15,806,000 | -32.9% | 277,306 | -6.1% | 0.01% | -30.0% |
| Q2 2018 | $23,573,000 | -9.1% | 295,214 | -1.3% | 0.01% | -9.1% |
| Q1 2018 | $25,921,000 | +26.7% | 299,078 | +0.9% | 0.01% | +22.2% |
| Q4 2017 | $20,464,000 | +29.3% | 296,407 | +70.2% | 0.01% | +28.6% |
| Q3 2017 | $15,823,000 | +22.8% | 174,108 | +0.6% | 0.01% | +16.7% |
| Q2 2017 | $12,880,000 | +29.1% | 173,046 | +62.5% | 0.01% | +20.0% |
| Q1 2017 | $9,980,000 | +45.5% | 106,510 | +12.8% | 0.01% | +66.7% |
| Q4 2016 | $6,859,000 | -10.7% | 94,403 | -43.0% | 0.00% | -25.0% |
| Q3 2015 | $7,685,000 | -99.9% | 165,672 | -0.1% | 0.00% | -20.0% |
| Q2 2015 | $8,910,407,000 | -11.1% | 165,775 | -20.8% | 0.01% | 0.0% |
| Q1 2015 | $10,027,004,000 | -12.5% | 209,201 | -29.4% | 0.01% | -16.7% |
| Q4 2014 | $11,463,876,000 | – | 296,454 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |